BVNKF

BAVARIAN NORDIC A S by Bavarian Nordic A/S (BVNKF)

About BAVARIAN NORDIC A S by Bavarian Nordic A/S (BVNKF)

Bavarian Nordic A/S engages in the business of developing, manufacturing, and commercializing cancer immunotherapies and vaccines for infectious diseases. The firm is involved in cancer immunotherapy including cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian, and prostate cancer. The company was founded on July 1, 1992 and is headquartered in Hellerup, Denmark.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$46.05
52 Week Low
$18.72
Market cap
1.7B
Dividend yield
0.00%
Volume
--
Avg. volume
229
P/E ratio
12.05

BAVARIAN NORDIC A S by Bavarian Nordic A/S News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$46.05
52 Week Low
$18.72
Market cap
1.7B
Dividend yield
0.00%
Volume
--
Avg. volume
229
P/E ratio
12.05